Skip to main content
. 2016 Jun 20;129(12):1483–1490. doi: 10.4103/0366-6999.183427

Figure 1.

Figure 1

Topical application of 2% TET inhibited AD-like symptoms induced by MC903 in BALB/c mice. (a) The ears of mice in AD group (left) and 2% TET group (right) at day 14. (b–d) Scoring of dermatitis (b), frequency of scratching (c), and ear thickness (d) at days 0, 1, 4, 7, 10, and 14. (e) Serum IgE levels in NC group, AD group, and 2% TET group. (f) Histopathology of the skin lesions was stained with H and E staining. Data were expressed as a mean ± SEM (*P < 0.05, †P < 0.01). NC: Naïve control; AD: Atopic dermatitis; TET: Tetracycline; SEM: Standard error of mean.